カルバペネム系抗生物質市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00027228
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

カルバペネム系抗生物質の市場規模は、2021 年の 39 億 6,457 万米ドルから 2028 年までに 53 億 4,662 万米ドルに成長すると予想されています。 2021 ~ 2028 年には 4.4% の CAGR で成長すると推定されています。

カルバペネムは、より広範な抗菌活性を持つ非定型 β-ラクタム系抗生物質の一種です。カルバペネム系抗生物質は、多くのグラム陽性菌、グラム陰性菌、好気性菌、嫌気性菌に対応できます。さらに、カルバペネム系抗生物質は、ほとんどのβ-ラクタマーゼに対して安定です。したがって、好中球減少症感染症や腹腔内感染症などのさまざまな重篤な症状に対する経験的単独療法として適応されています。

戦略的洞察


有病率の上昇グラム陰性細菌感染症の増加とジェネリック医薬品の生産増加が、カルバペネム系抗生物質市場の成長を促進しています。しかし、抗生物質開発の退屈で高価なプロセスが市場の成長を抑制しています。

世界のカルバペネム系抗生物質市場

< p>

市場洞察
グラム陰性細菌感染症の有病率の上昇

尿路感染症などのグラム陰性細菌感染症(UTI)、肺炎、血流感染症、創傷または手術部位の感染症、および髄膜炎は、一般的に患者が入院中に感染します。これらの感染症は一般に院内感染 (HAI) として知られています。集中治療室に入院する患者には、尿路感染症や肺炎などの感染症がよく見られます。米国国家医療安全ネットワークによると、HAI の 30% はグラム陰性菌が原因で、約 45% は UTI が原因で、約 47% は人工呼吸器関連肺炎 (VAP) が原因です。グラム陰性菌によって引き起こされる感染症の有病率は急速に増加しています。

さらに、グラム陰性菌感染症は複数の薬剤に対して耐性があり、利用可能な薬剤に対してより優れた耐性を獲得しています。抗生物質。抗菌薬耐性(AMR)は現代医療に対する世界的な脅威となっています。したがって、臨床分離株については、新たな傾向を継続的に監視する必要があります。ヨーロッパのラトビアの研究者グループは、さまざまなグラム陰性菌の AMR の進行を研究しました。 2021年6月にMDPIジャーナルに彼らが発表した研究論文によると、メロペネムやエルタペネムなどのカルバペネム系抗生物質がグラム陰性菌に対して最も効果的で、耐性率はそれぞれ3%と5.4%であった。これらの抗生物質はグラム陰性菌の治療薬として世界的に認められています。したがって、カルバペネム系抗生物質の高い需要は今後数年間続く可能性が高いと推定されています。

疾病管理予防センター (CDC) によると2020年は、新型コロナウイルス感染症(COVID-19)のパンデミックにより、HAI症例が増加しました。世界的に入院者数が増加しており、これにより、新型コロナウイルス感染症(COVID-19)患者の二次感染としてVAPのリスクが増加しています。この結果、カルバペネム系抗生物質の需要が高まり、市場を大きく助けています。

タイプベースの洞察

カルバペネム系抗生物質抗生物質市場は種類別にメロペネム、ドリペネム、イミペネム、テビペネムなどに分類されます。その他のセグメントは、2021年のカルバペネム系抗生物質市場で最大のシェアを占めており、予測期間中に市場で最高のCAGRを記録すると予想されています。カルバペネム系抗生物質の開発の進展は、将来の市場成長を牽引すると考えられます。

種類別カルバペネム系抗生物質市場シェア – 2021 年と 2028 年

適応症ベースの分析

適応症ごとに、カルバペネム系抗生物質市場は、細菌性髄膜炎、急性骨盤感染症、気道感染症、腹腔内感染症、尿路感染症などに分割されています。その他のセグメントは、2021年のカルバペネム系抗生物質市場で最大のシェアを占めており、予測期間中に市場で最高のCAGRを記録すると推定されています。細菌感染症の不確実性により、カルバペネムベースの抗生物質の需要が高まり、今後数年間で市場の成長を促進すると予想されています。

流通チャネルベースの洞察< /h3>

カルバペネム系抗生物質市場は、流通チャネル別に小売薬局、オンライン薬局、病院薬局に分割されています。病院薬局セグメントは、2021 年のカルバペネム系抗生物質市場で最大のシェアを占めており、予測期間中に市場で最高の CAGR を記録すると推定されています。

 

新製品の発売などの有機的な戦略は、市場での製品ポートフォリオを拡大するために企業によって一般的に採用されています。さらに、企業は合併・買収や提携など、さまざまな無機戦略を実行してきました。例えば、2021年5月、グランド・ファーマ・リミテッドはドクター・レディズ・ラボラトリーズ・リミテッドと協力して、INVANZ(注射用エルタペネム)のジェネリック版(注射用)1g/バイアルと同等の治療薬であるエルタペネム注射用1g/バイアルを発売した。米国食品医薬品局 (USFDA) によって承認されています。

会社概要

  • ファイザー株式会社
  • 救世主ライフテック
  • 大日本住友製薬株式会社
  • メルク&製薬株式会社株式会社
  • Gland Pharma Limited
  • Aurobindo Pharma Ltd
  • DAEWOONG PHARMACEUTICAL CO.,LTD
  • Iterum Therapeutics plc
  • ACS Dobfar SpA
  • Spero Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the carbapenem-based antibiotics?

Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.

What are the driving factors for the global carbapenem-based antibiotics market across the world?

The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.

Who are the major players in market the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.

Which segment is dominating the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.

The List of Companies - Carbapenem Based Antibiotics Market

  1. Pfizer Inc.
  2. Savior Lifetec
  3. Sumitomo Dainippon Pharma Co., Ltd.
  4. Merck & Co., Inc.
  5. Gland Pharma Limited
  6. Aurobindo Pharma Ltd
  7. Daewoong Pharmaceutical Co.,Ltd,
  8. Iterum Therapeutics plc
  9. ACS Dobfar S.p.A
  10. Spero Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports